By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Fibrocell Science, Inc. 

405 Eagleview Boulevard

Exton  Pennsylvania  19341  U.S.A.
Phone: 484-713-6000 Fax: 484-713-6001


SEARCH JOBS


Industry
Biotechnology






Company News
Fibrocell (FCSC) Reports First Quarter 2017 Financial Results And Recent Operational Highlights 5/10/2017 8:15:55 AM
Fibrocell (FCSC) Announces Data Safety Monitoring Board Recommends Continuation Of Phase I/II Clinical Trial Of FCX-007 For Treatment Of Recessive Dystrophic Epidermolysis Bullosa 5/8/2017 8:38:10 AM
Fibrocell (FCSC) To Host Conference Call And Webcast On Wednesday, May 10, 2017 To Discuss First Quarter 2017 Financial Results And Recent Operational Highlights 5/3/2017 7:36:24 AM
Fibrocell (FCSC) Regains Compliance With NASDAQ Listing Requirements 3/28/2017 11:10:56 AM
Fibrocell (FCSC) Announces One-For-Three Reverse Stock Split 3/10/2017 8:33:09 AM
Fibrocell (FCSC) Reports 2016 Financial Results and Recent Operational Highlights 3/9/2017 8:54:08 AM
Fibrocell (FCSC) To Host Conference Call And Webcast On Thursday, March 9, 2017 To Discuss 2016 Financial Results And Recent Operational Highlights 3/8/2017 8:17:32 AM
Fibrocell (FCSC) Announces Convertible Preferred Stock Financing For $8 Million 3/8/2017 8:11:46 AM
Fibrocell (FCSC) Announces Dosing Of First Patient In Phase I/II Clinical Trial Of FCX-007 Gene Therapy For Treatment Of Recessive Dystrophic Epidermolysis Bullosa 2/23/2017 8:18:14 AM
Fibrocell (FCSC) Announces FDA Fast Track Designation Of FCX-007 For Treatment Of Recessive Dystrophic Epidermolysis Bullosa 1/5/2017 7:35:47 AM
12345678910...
//-->